1. Public health importance of depression in pregnancy. Women of childbearing age are the demographic group at greatest risk for onset and prevalence of depression. Depression is especially common during pregnancy (1), and perinatal depression is a robust risk factor for postpartum depression (2). In addition to the major personal and societal impacts of depression in general, depression during pregnancy is associated with a wide range of negative outcomes for both mothers and infants (3). 2. Concerns Regarding Antidepressant Treatment in Pregnancy. Although antidepressant medication is frequently prescribed to treat depression in pregnancy (4, 5), there are important limitations to pharmacotherapy for perinatal depression. For example, two studies from MHRN sites have used medical records data to examine birth outcomes among infants exposed to antidepressants in utero, finding significantly increased risk for premature delivery, low birth weight, and perinatal complications (6, 7). Many women are reluctant to start or continue antidepressant medications due to concern about impact on the fetus (8). Many pregnant women disconfinue antidepressants, leading to a high rate of depression relapse (9). Pregnant women and their care providers considering antidepressant treatment must weigh the potential benefits of treating depression against the potential risks of neonatal exposure to antidepressants (10). 3. Efficacy and Transportability of Brief Psychotherapies. In contrast, psychological or behavioral interventions offer the promise of efficacy without the concerns regarding fetal or infant exposure to medications (11). Cognitive behavior therapy has been most widely investigated psychotherapy for depression, with recent research suggesting that the simple behavioral component (behavioral activation;BA) demonstrates benefit with respect to pharmacotherapy. In a recent placebo controlled trial conducted by Co-I Dimidjian and colleagues, BA, as compared to pharmacotherapy, was found to have comparable acute phase depression outcomes, superior rates of adherence to care, and enduring benefit following treatment terminafion (12, 13). These results are especially encouraging given that the BA approach may be more easily disseminated outside of specialty mental health care (14). Simon and colleagues also showed that a related intervention (including behavioral activation and brief cognitive re-structuring) was demonstrated to be an effective treatment for depression when delivered in a novel telephone based format (15, 16). 4. Inadequate Evidence Base for Psychological Treatment of Perinatal Depression. There is a surprising paucity of research examining non-pharmacological interventions among depressed pregnant women. In fact, only two randomized clinical trials in the US have been published (17, 18). Findings were promising;however, both were limited by small sample size and restriction of entry to low income women. Available data are not adequate to guide treatment decisions forthe general population of pregnant women with depression. 5. Pressing Need for Effectiveness Research. Research to inform pafients'and providers'decisions regarding depression treatment during pregnancy must consider overall effectiveness rather than simple efficacy. While pregnant women with depression may express a preference for psychotherapy over medication (see Preliminary Studies below), the stresses and competing priorities of pregnancy and postpartum create significant barriers to participation in traditional mental health treatments. Research must address the question """"""""Will this treatment prove acceptable and effective when delivered by real-worid providers to typical pafients treated in everyday practice settings?"""""""" rather than """"""""Will this treatment prove efficacious when delivered by research clinicians to highly motivated volunteers seeking treatment through a research center?"""""""" 6. Summary and Study Rationale. The significance of the proposed project, thus, is supported by four key points as evident in the literature reviewed here and in our own work (Preliminary Studies). Specifically, 1) untreated antenatal depression has serious adverse consequences for women and their offspring, 2) pharmacotherapy, the current standard of care, presents women and their care providers with complex riskbenefit decisions, 3) BA and related non-pharmacological treatments have demonstrated efficacy among depressed adults and are transportable to routine care settings, and 4) few studies have examined such intervenfions with pregnant women. The proposed MHRN provides an ideal setting in which to test innovative interventions for depressed pregnant women.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program--Cooperative Agreements (U19)
Project #
3U19MH092201-03S1
Application #
8530629
Study Section
Special Emphasis Panel (ZMH1-ERB-B)
Project Start
Project End
2014-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
3
Fiscal Year
2012
Total Cost
$20,046
Indirect Cost
$4,091
Name
Group Health Cooperative
Department
Type
DUNS #
078198520
City
Seattle
State
WA
Country
United States
Zip Code
98101
Becerra, Tracy A; Massolo, Maria L; Yau, Vincent M et al. (2017) A Survey of Parents with Children on the Autism Spectrum: Experience with Services and Treatments. Perm J 21:
Madden, Jeanne M; Lakoma, Matthew D; Lynch, Frances L et al. (2017) Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder. J Autism Dev Disord 47:144-154
Wolk, Courtney Benjamin; Jager-Hyman, Shari; Marcus, Steven C et al. (2017) Developing implementation strategies for firearm safety promotion in paediatric primary care for suicide prevention in two large US health systems: a study protocol for a mixed-methods implementation study. BMJ Open 7:e014407
Hacker, Karen; Penfold, Robert; Arsenault, Lisa N et al. (2017) The Impact of the Massachusetts Behavioral Health Child Screening Policy on Service Utilization. Psychiatr Serv 68:25-32
Dimidjian, Sona; Goodman, Sherryl H; Sherwood, Nancy E et al. (2017) A pragmatic randomized clinical trial of behavioral activation for depressed pregnant women. J Consult Clin Psychol 85:26-36
Boggs, Jennifer M; Simon, Gregory E; Ahmedani, Brian K et al. (2017) The Association of Firearm Suicide With Mental Illness, Substance Use Conditions, and Previous Suicide Attempts. Ann Intern Med 167:287-288
Zeber, John E; Coleman, Karen J; Fischer, Heidi et al. (2017) The impact of race and ethnicity on rates of return to psychotherapy for depression. Depress Anxiety 34:1157-1163
Penfold, Robert B; Stewart, Christine; Simon, Gregory E et al. (2017) Antidepressant Use by Youth with Minimal or Mild Depression: Evidence from 3 Health Systems. Pediatr Qual Saf 2:
Rossom, Rebecca C; Coleman, Karen J; Ahmedani, Brian K et al. (2017) Suicidal ideation reported on the PHQ9 and risk of suicidal behavior across age groups. J Affect Disord 215:77-84
Ahmedani, Brian K; Peterson, Edward L; Hu, Yong et al. (2017) Major Physical Health Conditions and Risk of Suicide. Am J Prev Med 53:308-315

Showing the most recent 10 out of 40 publications